BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28190473)

  • 61. MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway.
    Lin Z; Pan J; Chen L; Wang X; Chen Y
    Onco Targets Ther; 2020; 13():8149-8160. PubMed ID: 32884297
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
    Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surfactant protein A induces the pathogenesis of renal fibrosis through binding to calreticulin.
    Hao J; Zhao X; Yu W; Huang X; Huang Y
    Exp Ther Med; 2019 Jan; 17(1):459-464. PubMed ID: 30651822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rhein Induces Cell Death in HepaRG Cells through Cell Cycle Arrest and Apoptotic Pathway.
    You L; Dong X; Yin X; Yang C; Leng X; Wang W; Ni J
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614833
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1.
    Liu H; Cheng XH
    Oncotarget; 2018 Feb; 9(15):12304-12315. PubMed ID: 29552311
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of 5-hydroxy-4'-nitro-7-propionyloxy-genistein on inhibiting proliferation and invasion via activating reactive oxygen species in human ovarian cancer A2780/DDP cells.
    Bai J; Yang BJ; Luo X
    Oncol Lett; 2018 Apr; 15(4):5227-5235. PubMed ID: 29552162
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice.
    Kuppusamy P; Nagalingam A; Muniraj N; Saxena NK; Sharma D
    Sci Rep; 2017 Dec; 7(1):17943. PubMed ID: 29263422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling.
    Zhou XW; Xia YZ; Zhang YL; Luo JG; Han C; Zhang H; Zhang C; Yang L; Kong LY
    Oncotarget; 2017 Nov; 8(60):101965-101983. PubMed ID: 29254218
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liraglutide activates autophagy
    Chen J; Wang Z; Mao Y; Zheng Z; Chen Y; Khor S; Shi K; He Z; Li J; Gong F; Liu Y; Hu A; Xiao J; Wang X
    Oncotarget; 2017 Oct; 8(49):85949-85968. PubMed ID: 29156769
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo.
    Zhu J; Yu W; Liu B; Wang Y; Shao J; Wang J; Xia K; Liang C; Fang W; Zhou C; Tao H
    Cell Death Dis; 2017 Oct; 8(10):e3113. PubMed ID: 29022891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-proliferation of triple-negative breast cancer cells with physagulide P: ROS/JNK signaling pathway induces apoptosis and autophagic cell death.
    Yu P; Zhang C; Gao CY; Ma T; Zhang H; Zhou MM; Yang YW; Yang L; Kong LY
    Oncotarget; 2017 Sep; 8(38):64032-64049. PubMed ID: 28969050
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Wei RJ; Zhang XS; He DL
    Asian J Androl; 2018; 20(2):200-204. PubMed ID: 28869219
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
    Liu J; Wei X; Wu Y; Wang Y; Qiu Y; Shi J; Zhou H; Lu Z; Shao M; Yu L; Tong L
    Cell Oncol (Dordr); 2016 Aug; 39(4):333-42. PubMed ID: 27016209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation.
    Liu H; Xiao Y; Xiong C; Wei A; Ruan J
    Eur J Pharmacol; 2011 Mar; 654(3):209-16. PubMed ID: 21241688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human hepatocellular carcinoma: Protection by melatonin.
    Mortezaee K
    J Cell Physiol; 2018 Oct; 233(10):6486-6508. PubMed ID: 29672851
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Flavonoids as potential anti-hepatocellular carcinoma agents: recent approaches using HepG2 cell line.
    Xia JF; Gao JJ; Inagaki Y; Kokudo N; Nakata M; Tang W
    Drug Discov Ther; 2013 Feb; 7(1):1-8. PubMed ID: 23524937
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Eucalrobusone C suppresses cell proliferation and induces ROS-dependent mitochondrial apoptosis via the p38 MAPK pathway in hepatocellular carcinoma cells.
    Jian KL; Zhang C; Shang ZC; Yang L; Kong LY
    Phytomedicine; 2017 Feb; 25():71-82. PubMed ID: 28190473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 16-O-caffeoyl-16-hydroxylhexadecanoic acid, a medicinal plant-derived phenylpropanoid, induces apoptosis in human hepatocarcinoma cells through ROS-dependent endoplasmic reticulum stress.
    Huang RZ; Huang XC; Zhang B; Jia HY; Liao ZX; Wang HS
    Phytomedicine; 2018 Mar; 41():33-44. PubMed ID: 29519317
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.